1. Home
  2. ACAD vs TGNA Comparison

ACAD vs TGNA Comparison

Compare ACAD & TGNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACAD
  • TGNA
  • Stock Information
  • Founded
  • ACAD 1993
  • TGNA 1906
  • Country
  • ACAD United States
  • TGNA United States
  • Employees
  • ACAD N/A
  • TGNA N/A
  • Industry
  • ACAD Biotechnology: Pharmaceutical Preparations
  • TGNA Broadcasting
  • Sector
  • ACAD Health Care
  • TGNA Industrials
  • Exchange
  • ACAD Nasdaq
  • TGNA Nasdaq
  • Market Cap
  • ACAD 3.4B
  • TGNA 2.9B
  • IPO Year
  • ACAD 2004
  • TGNA N/A
  • Fundamental
  • Price
  • ACAD $19.95
  • TGNA $17.84
  • Analyst Decision
  • ACAD Buy
  • TGNA Strong Buy
  • Analyst Count
  • ACAD 19
  • TGNA 4
  • Target Price
  • ACAD $25.33
  • TGNA $21.75
  • AVG Volume (30 Days)
  • ACAD 1.6M
  • TGNA 993.2K
  • Earning Date
  • ACAD 02-26-2025
  • TGNA 02-27-2025
  • Dividend Yield
  • ACAD N/A
  • TGNA 2.80%
  • EPS Growth
  • ACAD N/A
  • TGNA N/A
  • EPS
  • ACAD 0.78
  • TGNA 2.81
  • Revenue
  • ACAD $929,236,000.00
  • TGNA $2,957,296,000.00
  • Revenue This Year
  • ACAD $36.88
  • TGNA $8.69
  • Revenue Next Year
  • ACAD $8.01
  • TGNA N/A
  • P/E Ratio
  • ACAD $25.70
  • TGNA $6.35
  • Revenue Growth
  • ACAD 47.06
  • TGNA N/A
  • 52 Week Low
  • ACAD $14.15
  • TGNA $12.35
  • 52 Week High
  • ACAD $26.56
  • TGNA $19.62
  • Technical
  • Relative Strength Index (RSI)
  • ACAD 60.25
  • TGNA 41.43
  • Support Level
  • ACAD $19.52
  • TGNA $17.81
  • Resistance Level
  • ACAD $20.29
  • TGNA $18.38
  • Average True Range (ATR)
  • ACAD 0.68
  • TGNA 0.35
  • MACD
  • ACAD 0.08
  • TGNA -0.03
  • Stochastic Oscillator
  • ACAD 72.62
  • TGNA 12.90

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

About TGNA TEGNA Inc

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

Share on Social Networks: